Sponsor Pipeline

National Institute of Cardiovascular Diseases, Pakistan Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
10
Active Trials
7
Recruiting
3
Phase 3
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-20 NCT07714746 Ivabradine in the Acute Management of Cardiogenic Shock Phase 3 Recruiting
Active Trials by Phase
Phase 4
2
Phase 3
3
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07536802 Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction (STEMI) Recruiting
NCT07697833 Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart… Heart Failure With Reduced Ejection Fraction (HFrEF) Not Yet Recruiting
Phase 3
NCT06742567 Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior… Acute Myocardial Infarction of Anterior Wall Recruiting
NCT07229248 DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial STEMI (ST Elevation MI) Recruiting
NCT07714746 Ivabradine in the Acute Management of Cardiogenic Shock Cardiogenic Shock Post Myocardial Infarction Recruiting
Not specified
NCT05991219 Screening and Secondary Prevention Rheumatic Heart Disease Study Rheumatic Heart Disease Recruiting
NCT06004544 Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant… Cardiovascular Diseases in Pregnancy Recruiting
NCT06503341 A Hospital-Based Registry of Preventive Cardiology Clinics Cardiovascular Morbidity Recruiting
NCT07355452 Comparing Outcomes Of Single Layer Versus Multilayer Leg Closure Techniques Following… Surgical Wound Infection Enrolling by Invitation
NCT05510661 Use of Export in Primary Percutaneous Coronary Intervention ST-segment Elevation Myocardial Infarction (STEMI) Active, Not Recruiting
Disease Areas
Get alerts when National Institute of Cardiovascular Diseases, Pakistan's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free